Specifically, it showed the ability to inhibit the expression of phosphorylated STAT3 and its downstream genes (e.g., Survivin, Cyclin D1, COX-2 and cMyc) in glioma cell lines (Yang et al., 2012b). The gene discussed is BIRC5; the disease is central nervous system cancer.